Naltrexone Hydrochloride; Oxycodone Hydrochloride Patent Expiration

Naltrexone Hydrochloride; Oxycodone Hydrochloride is Used for managing severe, long-term pain that requires daily opioid treatment. It was first introduced by Pfizer Inc in its drug Troxyca Er on Aug 19, 2016.


Naltrexone Hydrochloride; Oxycodone Hydrochloride Patents

Given below is the list of patents protecting Naltrexone Hydrochloride; Oxycodone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Troxyca Er US7815934 Sequestering subunit and related compositions and methods Dec 12, 2027 Pfizer
Troxyca Er US8685443 Sequestering subunit and related compositions and methods Jul 03, 2025 Pfizer



Naltrexone Hydrochloride; Oxycodone Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List